InvestorsHub Logo
Followers 1183
Posts 134793
Boards Moderated 3
Alias Born 08/27/2003

Re: Rawnoc post# 174600

Tuesday, 11/25/2008 10:17:27 AM

Tuesday, November 25, 2008 10:17:27 AM

Post# of 275592
REPR -- 11/25/08 thoughts:

REPR -- profitable, rapidly growing, recession-proof, tiny float...

(1) After turning the corner of profitability a couple of quarters ago, sales and net income are starting to blow up:
http://biz.yahoo.com/e/081015/repr.ob10-q.html

(2) Expecting their quarterly performance to accelerate:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=32890792
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=32890827

(3) Tiny market cap, shares outstanding, and float.
http://finance.yahoo.com/q/ks?s=REPR.OB

(4) Products are recession-proof with no direct competition with sales rapidly expanding due to a new treatment (Vivaglobin) where their infusion pump is the best, cheapest, safest, and most convenient form of delivery:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28775119
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28777209
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28838178

(5) They are hiring like crazy:
http://www.rmsmedicalproducts.com/Careers.htm
http://investorshub.advfn.com/boards/read_msg.asp?message_id=24616830

(6) Medicare reimbursement for the Freedom60 (their biggest & most exciting revenue-generating product) was increased 20 fold in June of 2007 and is the ONLY infusion pump accepted by Medicare for reimbursement for Subcutaneous Immune Globulin treatment (Vivaglobin):
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28776642
http://investorshub.advfn.com/boards/read_msg.asp?message_id=28776847

(7) Additional products are being released this year as well as more products are in development.

Based on last Q, REPR is growing so fast with such large margins that I think they are 1 or 2 quarters away from +.02 EPS per quarter or more or an annualized +.08 EPS pace IMO. Possibly 2-3 quarters away from +.03 EPS per Q or an annualized +.12 EPS. A mere 15 PE with rapid recession-proof growth = $1.80/share.

More REPR INFO and Board:
http://investorshub.advfn.com/boards/board.aspx?board_id=201

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.